C-reactive Protein Testing Market & Trends
The global C-reactive protein testing market size is expected to reach USD 5.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 0.3% from 2021 to 2028. The market growth can be attributed to substantial research activities to explore the applications of C-reactive protein (CRP) testing coupled with the presence of private as well as public agencies which grant funds to expedite the research proceedings in this arena.
A rise in the number of strategic deals and developments coupled with the increase in investments for R&D of C-reactive protein testing is expected to drive the market significantly. The ongoing COVID-19 pandemic has affected the CRP testing market to a great extent. As CRP is considered to be the determining biomarker for the severity of infection/inflammation, the market is witnessing increased demand for CRP testing services and products. Major operating companies such as Abbott offer supportive tools for CRP testing for SARS-CoV-2 infection.
The development of novel technologies to analyze CRP concentration is a high-impact rendering driver for market growth. The emergence and advances in nano-technological tools are expected to provide an attractive perspective in designing portable bioanalytical assays with high specificity and sensitivity, faster response time, and multiplexing capabilities for on-site accurate disease diagnosis, and monitoring. Plasmonic nanoparticles (PNPs) is a tool that can be used for bio-sensing applications owing to their versatile optical properties.
Request a free sample copy or view report summary: C-reactive Protein Testing Market Report
C-reactive Protein Testing Market Report Highlights
- The immunoturbidimetric assay generated the largest revenue share amongst all the assay types in 2020 owing to the development and launch of the highly sensitive, automated, and less expensive immunoturbidimetric assay with a broad measuring range for the levels of C-reactive protein in samples
- hs-CRP was the highest revenue-generating detection range segment in 2020 as it features a broad detection range as compared to conventional CRP
- Cardiovascular diseases are the most common application of c-reactive protein testing and is anticipated to dominate the market throughout the analysis period
- This is because of the high adoption rate of c-reactive protein tests to detect inflammation in arteries and thus patients at high risk for heart attack, stroke, peripheral arterial diseases, and other cardiovascular disorders
- The hospitals segment registered the market share in 2020 owing to the rising penetration of CRP testing in hospitals, especially after the COVID-19 pandemic, and thereby increase in the testing rate
- North America accounted for the largest market share in 2020. This can be attributed to various factors such as well-established healthcare infrastructure, supportive government policies, and high R&D investments in the region
- In addition, the rising incidence of chronic heart diseases and cancers is also one of the major factors responsible for market growth
- The Asia Pacific is projected to grow at the fastest pace. The COVID-19 pandemic was originated in China. Being the potential biomarker for determining the severity of the infection and the rapidly increasing number of COVID-19 cases in Asian countries, the demand for CRP testing is expected to increase in the near future
- According to an article published in June 2021, doctors are recommending CRP testing for the COVID-19 patients with critical conditions who are in hospital care. This is expected to increase the demand, in turn, driving the market
- These companies are involved in their business expansion through the launch of novel products and expand their market presence through agreements, partnerships, and other initiatives
Access Press Release@ https://www.grandviewresearch.com/press-release/c-reactive-protein-crp-testing-market
C-reactive Protein Testing Market Segmentation
Grand View Research has segmented the global C-reactive protein testing market on the basis of assay type, detection range, disease area, end-use, and region:
C-reactive Protein Testing Assay Type Outlook (Revenue, USD Million, 2017 - 2028)
- Immunoturbidimetric Assay
- ELISA
- Clinical
- Non-clinical
- Chemiluminescence Immunoassay
- Others
C-reactive Protein Testing Detection Range Outlook (Revenue, USD Million, 2017 - 2028)
- hs-CRP
- Conventional CRP
- cCRP
C-reactive Protein Testing Disease Area Outlook (Revenue, USD Million, 2017 - 2028)
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
C-reactive Protein Testing End-use Outlook (Revenue, USD Million, 2017 - 2028)
- Clinics
- By Entity
- Physician Offices
- Small Clinics
- Others
- By Settings
- Urban Setting
- Rural Setting
- Hospitals
- Urban Setting
- Rural Setting
- Laboratories
- Urban Setting
- Rural Setting
- Assisted Living Healthcare Facilities
- Urban Setting
- Rural Setting
- Home
- Others
- By Entity
C-reactive Protein Testing Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- US.
- Canada
- Europe
- Germany
- UK.
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Middle East and Africa (MEA)
- South Africa
List of Key Players of C-reactive Protein Testing Market
- Thermo Fisher Scientific, inc.
- Hoffmann-La Roche Ltd
- Danaher
- Quest Diagnostics
- Siemens Healthineers AG
- Abbott
- Merck KGaAA
- Zoetis
- Ortho Clinical Diagnostics
- Getein Biotech, Inc
- HORIBA, Ltd
- Randox Laboratories Ltd
- BODITECH MED, INC.
- Aidian
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.